Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Omeros Corp (NQ: OMER ) 3.790 -0.230 (-5.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Omeros Corp < Previous 1 2 3 4 5 6 7 8 Next > Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 September 27, 2021 Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: Via Benzinga Looking Into Omeros's Return On Capital Employed September 20, 2021 According to data from Benzinga Pro, during Q2, Omeros's (NASDAQ:OMER) reported sales totaled $28.82 million. Despite a 21.55% increase in earnings, the company posted a loss of $... Via Benzinga Omeros: Q2 Earnings Insights August 09, 2021 Shares of Omeros (NASDAQ:OMER) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 24.59% year over year to... Via Benzinga Earnings Scheduled For May 10, 2021 May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... Via Benzinga Omeros Corporation Reports Second Quarter 2021 Financial Results August 09, 2021 From Omeros Corporation Via Business Wire Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021 August 03, 2021 From Omeros Corporation Via Business Wire Return On Capital Employed Overview: Omeros June 24, 2021 Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. In Q4, Omeros brought in $10.... Via Benzinga Omeros' Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant Patients June 14, 2021 Omeros Corporation (NASDAQ: OMER) has announced the presentation of data on organ function improvement from its pivotal trial of narsoplimab for the treatment of... Via Benzinga Earnings Scheduled For August 9, 2021 August 09, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... Via Benzinga Omeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 2021 Annual Congress of the European Hematology Association June 14, 2021 From Omeros Corporation Via Business Wire Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction June 10, 2021 From Omeros Corporation Via Business Wire Omeros to Present at the BofA 2021 Napa BioPharma Virtual Conference June 09, 2021 From Omeros Corporation Via Business Wire Omeros Announces Preliminary Results from Phase 1 Clinical Trial of OMS906 June 09, 2021 From Omeros Corporation Via Business Wire Omeros: Return On Capital Employed Insights June 08, 2021 Omeros (NASDAQ:OMER) reported Q1 sales of $21.06 million. Earnings fell to a loss of $30.61 million, resulting in a 9.47% decrease from last quarter. Omeros collected $10.63... Via Benzinga Omeros's Narsoplimab Shows Encouraging Action In Critically Ill COVID-19 Patients May 28, 2021 Omeros Corporation (NASDAQ: OMER) has announced preliminary results from the second cohort (n=10) of critically ill COVID-19 patients treated with narsoplimab in... Via Benzinga Exposures COVID-19 Omeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with Narsoplimab May 28, 2021 From Omeros Corporation Via Business Wire 60 Biggest Movers From Yesterday May 21, 2021 Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 20, 2021 Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of... Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 20, 2021 Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-... Via Benzinga Omeros's Narsoplimab US Application Review Pushed By 3 Months, Shares Drop May 20, 2021 Omeros Corporation (NASDAQ: OMER) has revealed that the FDA needs additional time to review narsoplimab marketing application for hematopoietic stem cell... Via Benzinga Exposures Product Safety Omeros Announces Extension of FDA Review Period for Narsoplimab in HSCT-TMA May 20, 2021 From Omeros Corporation Via Business Wire Omeros’ Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentation at the European Hematology Association Congress May 13, 2021 From Omeros Corporation Via Business Wire Omeros: Q1 Earnings Insights May 10, 2021 Shares of Omeros (NASDAQ:OMER) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 7.55% over the past year to... Via Benzinga Omeros Corporation Reports First Quarter 2021 Financial Results May 10, 2021 From Omeros Corporation Via Business Wire Omeros Corporation to Announce First Quarter Financial Results on May 10, 2021 May 05, 2021 From Omeros Corporation Via Business Wire The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety Omeros Corporation Announces Approval of ICD-10 Codes for HSCT-TMA Diagnosis and for Narsoplimab Administration May 04, 2021 From Omeros Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.